GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) was the recipient of a significant decline in short interest in the month of May. As of May 15th, there was short interest totaling 13,670 shares, a decline of 40.8% from the April 30th total of 23,087 shares. Based on an average trading volume of 97,480 shares, the days-to-cover ratio is presently 0.1 days.
GeneDx Price Performance
Shares of WGSWW stock traded up $0.00 during mid-day trading on Thursday, reaching $0.01. The stock had a trading volume of 14,426 shares, compared to its average volume of 73,185. GeneDx has a 52-week low of $0.00 and a 52-week high of $0.13. The stock’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.02.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Further Reading
- Five stocks we like better than GeneDx
- The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker
- Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
- Gen Z Trends Make These 3 Stocks Worth Watching
- How the Memory Shortage Is Crushing the Gaming Industry
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
